Nascent Biotech Overview

  • Status
  • Public

  • Stock Symbol
  • NBIO

Stock Symbol

  • Investments
  • 1

Nascent Biotech General Information

Description

Nascent Biotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is focused on the development and delivery of human antibodies and cytokine responses to the treatment of cancer. The company's products include Pritumumab, CLNH5, and MultiPharm. The company is engaged in the development of Pritumumab which would be used for the treatment of brain cancer and pancreatic cancer. The company is also exploring the use of Pritumumab against other viruses.

Contact Information

Formerly Known As
Jin-En International Group Holding Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 6330 Nancy Ridge Drive
  • Suite 105
  • San Diego, CA 92121
  • United States
+1 (772)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 6330 Nancy Ridge Drive
  • Suite 105
  • San Diego, CA 92121
  • United States
+1 (772)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nascent Biotech Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
60.7K

Nascent Biotech Financials Summary

As of 30-Jun-2024, Nascent Biotech has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 14,590 30,816 6,914 6,304
Revenue 0 0 0 1,000
EBITDA (1,781) (1,708) (1,078) (134)
Net Income (1,925) (2,088) (2,801) (470)
Total Assets 227 552 255 105
Total Debt 59 122 390 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nascent Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nascent Biotech‘s full profile, request access.

Request a free trial

Nascent Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nascent Biotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is focused on the dev
Drug Discovery
San Diego, CA

Tokyo, Japan
 

Karmiel, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nascent Biotech Competitors (115)

One of Nascent Biotech’s 115 competitors is Astellas Pharma, a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astellas Pharma Corporation Tokyo, Japan
Protalix Biotherapeutics Formerly VC-backed Karmiel, Israel
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Nexoplex bio Formerly VC-backed Emeryville, CA
Bridge Medicines Venture Capital-Backed New York, NY
You’re viewing 5 of 115 competitors. Get the full list »

Nascent Biotech Patents

Nascent Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021471595-A1 Kits and containers for treating vimentin expressing tumors Inactive 29-Oct-2021
CA-3236114-A1 Kits and containers for treating vimentin expressing tumors Pending 29-Oct-2021
EP-4422683-A1 Kits and containers for treating vimentin expressing tumors Inactive 29-Oct-2021
EP-4422683-A4 Kits and containers for treating vimentin expressing tumors Inactive 29-Oct-2021
US-11492394-B1 Kits and containers for treating vimentin expressing tumors Active 29-Oct-2021 A61P35/00
To view Nascent Biotech’s complete patent history, request access »

Nascent Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nascent Biotech‘s full profile, request access.

Request a free trial

Nascent Biotech Acquisitions (1)

Nascent Biotech’s most recent deal was a Merger/Acquisition with Jin-En International Group Holding. The deal was made on 29-Jul-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jin-En International Group Holding 29-Jul-2014 Merger/Acquisition Biotechnology
To view Nascent Biotech’s complete acquisitions history, request access »

Nascent Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Nascent Biotech’s complete esg history, request access »

Nascent Biotech FAQs

  • Where is Nascent Biotech headquartered?

    Nascent Biotech is headquartered in San Diego, CA.

  • What industry is Nascent Biotech in?

    Nascent Biotech’s primary industry is Drug Discovery.

  • Is Nascent Biotech a private or public company?

    Nascent Biotech is a Public company.

  • What is Nascent Biotech’s stock symbol?

    The ticker symbol for Nascent Biotech is NBIO.

  • Who are Nascent Biotech’s competitors?

    Astellas Pharma, Protalix Biotherapeutics, Renova Therapeutics, Nexoplex bio, and Bridge Medicines are some of the 115 competitors of Nascent Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process